NVNOW

enVVeno Medical Corporation Warrants

Delisted

NVNOW was delisted on the 26th of May, 2023.

 

About: enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Employees: 30

Charts implemented using Lightweight Charts™